Allograft Reconstruction after Bone Tumour Resection

OncologyAdvancedCore Procedure

Allograft Reconstruction after Bone Tumour Resection

Surgical technique for structural fresh-frozen allograft reconstruction of segmental bone defects after wide resection of bone sarcomas and aggressive benign tumours — intercalary, osteoarticular and allograft-prosthesis composite options, fixation principles, junction union strategies and complication management

High-yield overview

Structural fresh-frozen allograft reconstruction of segmental defects after wide resection | advanced

Surgical Imaging

Critical Danger Structures and Exam Traps
Host-Graft Junction Biology

The trap: Treating the host-graft junction like a standard fracture — the allograft is avascular and provides no living cells or growth factors; union depends entirely on creeping substitution from the host.

The fix: Achieve absolute stability with compression plating or IM nailing spanning at least two cortical diameters on each side. Impact fresh autograft (iliac crest or reamings) circumferentially at both junctions. Avoid gaps greater than 1 mm. Chemotherapy and radiation delay union — plan for longer protected weight-bearing.

Allograft Fracture Risk

Location: Stress risers at screw holes, the junction itself, or within the graft diaphysis where vascular ingrowth is incomplete.

Risk: 5-15 percent incidence; higher with osteoarticular allografts and when adjuvant radiation is used. The graft never fully remodels to living bone — it remains a structural scaffold prone to fatigue failure.

Prevention: Use the largest diameter IM nail possible or multiple plates in different planes. Avoid unnecessary screw holes. Protect the reconstruction until radiographic union (minimum 6 months, often 12-18 months).

Infection — The Defining Complication

Why different: The allograft is a large avascular foreign body. Deep infection rates (5-15 percent) exceed those of megaprosthesis. Once infected, eradication usually requires graft removal, prolonged antibiotics and staged reconstruction.

Prevention: Strict aseptic technique, laminar-flow theatre, perioperative antibiotics for 24-48 hours (or longer if chemotherapy-induced neutropenia), meticulous soft-tissue coverage and muscle flaps when needed. Any post-operative wound issue must be treated aggressively.

Soft-Tissue and Tendon Reattachment

The principle: One of the main advantages of allograft over megaprosthesis is the ability to reattach host tendons and ligaments directly to the graft (patellar tendon, rotator cuff, hip abductors).

Technique: Use heavy non-absorbable sutures through drill holes in the graft or through the preserved soft-tissue envelope on the allograft. For osteoarticular grafts, reconstruct the joint capsule and ligaments as in a revision arthroplasty.

Failure mode: Poor reattachment leads to instability, subluxation or dislocation — particularly devastating in proximal humerus or proximal tibia reconstructions.

Disease Transmission and Graft Quality

Risk: Viral transmission (HIV, hepatitis) is now less than 1 in 1 million with modern screening, but bacterial contamination during procurement or processing remains a concern.

Selection: Use only grafts from accredited tissue banks with negative cultures, serology and irradiation (where indicated). Size matching is critical — a graft more than 2 mm smaller in diameter than the host canal leads to poor fit and fixation failure.

Storage: Fresh-frozen at minus 80 degrees Celsius is standard; never use freeze-dried grafts for structural applications because of reduced mechanical strength.

Allograft versus Megaprosthesis Decision

The trap: Offering allograft to every young patient without considering the higher early complication rate and slower rehabilitation.

The reality: Allograft offers superior long-term bone stock and biologic attachment but at the cost of 20-40 percent major complication rate in the first two years. Megaprosthesis provides immediate stability and faster return to function but sacrifices future revision options.

Decision factors: Patient age, defect location (diaphyseal favours intercalary allograft), need for tendon attachment, anticipated adjuvant therapy, and patient tolerance for prolonged protected weight-bearing.

Mnemonic

G.R.A.F.TGRAFT — Structural Allograft Principles

Mnemonic

U.N.I.O.NUNION — Monitoring and Managing Host-Graft Junctions

Mnemonic

I.N.F.E.C.TINFECT — Prevention and Management of Allograft Infection

Surgical Indications

Absolute Indications

  • Diaphyseal or intercalary segmental defect after wide resection of bone sarcoma (osteosarcoma, Ewing sarcoma, chondrosarcoma) in a patient younger than 40-50 years who desires biologic reconstruction and restoration of bone stock
  • Osteoarticular defect requiring joint surface and ligament reconstruction (proximal tibia, distal femur, proximal humerus) when the patient is young and high-demand
  • Need for tendon or ligament attachment sites that cannot be achieved with a megaprosthesis (patellar tendon, hip abductors, rotator cuff)
  • Patient preference for allograft after informed discussion of risks versus endoprosthetic reconstruction

Relative Indications

  • Allograft-prosthesis composite (APC) when the joint surface is not reconstructible with osteoarticular allograft but soft-tissue attachment is still desired
  • Revision of failed megaprosthesis where bone stock restoration is required for future longevity
  • Aggressive benign tumours (giant cell tumour, chondroblastoma) with massive bone loss after curettage and resection

Contraindications

Absolute:

  • Active infection at the resection site
  • Inability to achieve wide surgical margins
  • Patient non-compliance with prolonged protected weight-bearing (minimum 6 months)
  • Severe immunocompromise or uncontrolled diabetes with high infection risk

Relative:

  • Age greater than 60-65 years (megaprosthesis usually preferred for faster rehabilitation)
  • Requirement for post-operative radiation (increases nonunion and fracture risk)
  • Smoking or poor soft-tissue envelope that cannot be optimised

Evidence for Allograft Reconstruction

Structural Allograft Outcomes

  • Fresh-frozen structural allografts achieve union in 60-80 percent of host-graft junctions when rigid fixation and autograft augmentation are used
  • Osteoarticular allografts have higher complication rates (fracture, joint degeneration) than intercalary grafts but preserve the option for biologic joint reconstruction in young patients
  • Allograft-prosthesis composites combine the advantages of both techniques and are particularly useful in the proximal tibia where patellar tendon reattachment is critical

Comparison with Megaprosthesis

  • Megaprosthesis provides immediate stability and faster return to weight-bearing (6-12 weeks) but sacrifices bone stock and future revision options
  • Allograft reconstruction offers superior long-term bone stock and the possibility of tendon/ligament attachment but requires 6-18 months of protected weight-bearing and carries a 20-40 percent major complication rate in the first two years
  • In patients younger than 40 years with diaphyseal defects, many centres favour allograft or allograft-prosthesis composite when the soft-tissue envelope allows

Key Evidence

Evidence

Long-term results of allograft reconstruction after resection of bone tumours

Level III
Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WWClin Orthop Relat Res
Clinical implication: Structural allograft reconstruction can provide durable limb salvage in appropriately selected patients when the host-graft junctions unite; careful patient selection and meticulous surgical technique are essential.
Source: Clin Orthop Relat Res 1996;(324):86-97
Evidence

Allograft-prosthesis composite reconstruction of the proximal tibia after tumour resection

Level III
Biau DJ, Dumaine V, Babinet A, Tomeno B, Anract PJ Bone Joint Surg Am
Clinical implication: APC is a valuable option when patellar tendon reconstruction is required; the biologic attachment improves quadriceps function compared with direct suture to a megaprosthesis.
Source: Clin Orthop Relat Res 2007;456:211-7
Evidence

Allograft reconstruction of intercalary defects after bone tumour resection

Level IV
Gebhardt MC, Flugstad DI, Springfield DS, Mankin HJClin Orthop Relat Res
Clinical implication: Intercalary allograft is particularly suitable for young patients with purely diaphyseal tumours where the joints can be preserved.
Source: Clin Orthop Relat Res 1991;(270):181-96
Evidence

Observations on massive retrieved human allografts

Level IV
Enneking WF, Mindell ERJ Bone Joint Surg Am
Clinical implication: Retrieved allograft studies confirm that the central graft remains avascular indefinitely; fixation must protect the junctions until union and account for the limited remodeling capacity of structural allografts.
Source: J Bone Joint Surg Am 1991;73(8):1123-42

Clinical Decision Scenarios

Practise clinical reasoning and management decisions out loud

Viva scenarioAdvanced
Clinical prompt

A 28-year-old man undergoes wide resection of a distal femoral osteosarcoma with a 12 cm intercalary defect. He has completed neoadjuvant chemotherapy and is eager to return to construction work. Discuss your choice of reconstruction and the key technical points.

Practical approach
In a young, high-demand patient with a purely diaphyseal defect, structural fresh-frozen intercalary allograft offers the best chance of durable biologic reconstruction and restoration of bone stock for future revision surgery. **Pre-operative planning**: I would obtain CT of the entire femur and the contralateral limb for precise size matching. The allograft must be within 1-2 mm of the host canal diameter. I would plan rigid fixation spanning both junctions with either dual compression plates in different planes or a large-diameter locked IM nail supplemented by a plate at the junctions. **Key technical points**: Achieve absolute compression at both host-graft junctions with lag screws or a compression device before locking the construct. Impact autograft circumferentially at both junctions. Ensure at least two cortical diameters of host bone overlap on each side. Reattach any resected quadriceps or other soft tissues to the graft. Plan for muscle flap coverage if the soft-tissue envelope is tenuous. **Rehabilitation**: Protected weight-bearing for a minimum of 6 months, often 12-18 months, until radiographic union. Serial radiographs to monitor junction healing. Counsel the patient that return to heavy construction work may be limited and that high-impact activities carry a lifelong risk of graft fracture. **Alternative discussion**: I would also discuss megaprosthesis as an option that allows faster rehabilitation (6-12 weeks) but sacrifices bone stock and future revision options. In a 28-year-old, the biologic advantages of allograft usually outweigh the slower recovery if the patient accepts the risks.
Viva scenarioAdvanced
Clinical prompt

A 35-year-old woman with a proximal tibial giant cell tumour has undergone wide resection with sacrifice of the patellar tendon insertion. She desires reconstruction that maximises her chance of returning to recreational running. Compare allograft-prosthesis composite versus megaprosthesis.

Practical approach
This patient requires both joint reconstruction and patellar tendon reattachment. An allograft-prosthesis composite (APC) offers the best combination of immediate prosthetic joint stability and biologic tendon attachment. **Why APC over osteoarticular allograft**: The proximal tibial articular surface is difficult to reconstruct reliably with osteoarticular allograft; joint degeneration rates are high. APC provides a cemented prosthetic joint surface with the patellar tendon attached to the allograft portion of the composite. **Why APC over megaprosthesis**: Direct suture of the patellar tendon to a megaprosthesis provides inferior extensor mechanism function and higher rates of patellar tendon rupture or insufficiency. The allograft in an APC allows transosseous tendon reattachment with better healing potential. **Technical points**: The cemented prosthesis is implanted into the allograft on the back table. The composite is then fixed to the host tibia with spanning fixation and autograft at the junction. The patellar tendon is reattached to the allograft tibial tubercle with heavy non-absorbable suture through drill holes. A gastrocnemius flap is often required for soft-tissue coverage. **Rehabilitation**: Protected weight-bearing for 3-6 months until junction union; the prosthetic joint allows earlier motion than osteoarticular allograft. Extensor mechanism protection with a brace for 6-12 weeks. Serial monitoring for both prosthetic loosening and junction union.
Viva scenarioAdvanced
Clinical prompt

A 42-year-old man with a distal femoral osteosarcoma treated with neoadjuvant chemotherapy and wide resection with intercalary allograft reconstruction now presents at 16 months with persistent pain on weight-bearing. Radiographs show no bridging callus at the proximal host-graft junction and a 2 mm gap. How do you approach this?

Practical approach
This is a nonunion at the host-graft junction. I would first exclude low-grade infection with aspiration or biopsy before planning revision. **Investigation**: CT scan to assess the gap, hardware integrity and any callus. CRP, ESR and white cell count. Aspiration of the junction under sterile conditions for culture (including sonication if hardware present). Bone scan or PET-CT if infection is suspected. **Management if infection excluded**: Revision surgery with compression plating (or exchange nailing if appropriate) and additional autograft (iliac crest or vascularised fibula transfer). Ensure absolute stability and compression at the junction. Optimise nutrition, stop smoking and consider bone stimulator post-operatively. **If infection confirmed**: Staged management with hardware removal, debridement, antibiotic spacer and culture-specific IV antibiotics for 6-8 weeks, followed by revision to megaprosthesis once infection is cleared. Repeat allograft is rarely successful after established infection. **Prognosis**: With revision and autograft, union can be achieved in 60-70 percent of cases, but multiple revisions may be required. Conversion to megaprosthesis remains the salvage option if biology cannot be overcome.
Exam day cheat sheet
Allograft Reconstruction after Bone Tumour Resection — Exam Day Summary

References

Editorially reviewed — transparent references and correction processPublished by OrthoVellum Medical Education TeamEditorial boardMethodologyReview policy
Educational disclosure

Educational content is reviewed for source visibility, editorial coherence, and correction readiness.

No individual clinician credential is claimed unless a named person is shown.

Verify before clinical use; this is not medical advice or a substitute for local guidance.